Walt Disney Co. (DIS.US) has announced a groundbreaking partnership with OpenAI, investing £1 billion in the AI start-up and becoming the first major licensing partner for the Sora platform. The three-year agreement includes the provision of over 200 animated characters from the Disney, Marvel, Pixar and Star Wars libraries for video content generation. A key limitation of the agreement is the exclusion of celebrity images and actors' voices, meaning that generated videos may include visual characters but not the original performers' voices. Additionally, some user-generated videos will be available on the Disney+ platform, creating a new distribution channel for AI content.
In addition to capital investment and trademark licensing, Disney is becoming a major customer of OpenAI and will implement the start-up's tools to create new products, services and experiences for Disney+, while also making ChatGPT available to its employees. This decision marks a significant shift in Hollywood's attitude towards AI technology, representing a turning point for the entertainment industry, which had previously expressed concerns about the impact of artificial intelligence on creators' rights and job security. CEO Bob Iger emphasised that the partnership will allow them to "carefully and responsibly expand the reach of our storytelling through artificial intelligence, while respecting and protecting creators and their work." Both Disney and OpenAI have committed to implementing responsible safety measures, including age-appropriate policies and controls to prevent the generation of harmful content, demonstrating a shared commitment to the ethical use of AI in entertainment.
The company's shares are gaining over 1% today following these announcements and are testing the 200- and 100-day EMAs, which can be considered key zones indicating the continuing downward trend in the company's shares.
Source: xStation
Daily summary: SILVER at a new ATH, EURUSD at its highest since October
Stock of the Week – Jabil Inc (11.12.2025)
Rivian is developing its own AI chip for autonomous driving 💡
DE40: DAX slightly loses📉Carl Zeiss Meditec under pressure after earnings
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
